Academic Journals Database
Disseminating quality controlled scientific knowledge

OncoTargets and Therapy

ISSN: 1178--6930
Publisher: Dove Press


ADD TO MY LIST
 
Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma

Author(s): Hirte HW
Volume: 2013
Issue: default
Year: 2013
Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells

Author(s): Castellanos JA | Merchant NB | Nagathihalli NS
Volume: 2013
Issue: default
Year: 2013
Critical analysis of the potential for targeting STAT3 in human malignancy

Author(s): Peyser ND | Grandis JR
Volume: 2013
Issue: default
Year: 2013
Antitumor effects of inductive hyperthermia using magnetic ferucarbotran nanoparticles on human lung cancer xenografts in nude mice

Author(s): Araya T | Kasahara K | Nishikawa S | Kimura H | Sone T | Nagae H | Ikehata Y | Nagano I | Fujimura M
Volume: 2013
Issue: default
Year: 2013
Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma

Author(s): Peng HH | Zhang YD | Gong LS | Liu WD | Zhang Y
Volume: 2013
Issue: default
Year: 2013
Molecular guided therapy for advanced pancreatic cancer patients with PI3K activated mutation: vision or illusion?

Author(s): Gazzah A | Gonzales DB | Levy A | Bahleda R | Ducreux M | Lacroix L | Soria JC
Volume: 2013
Issue: default
Year: 2013
Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer

Author(s): Wang Z | Wang Z | Liang Z | Liu J | Shi W | Bai P | Lin X | Magaye R | Zhao J
Volume: 2013
Issue: default
Year: 2013
An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer

Author(s): Rick FG | Block NL | Schally AV
Volume: 2013
Issue: default
Year: 2013
Antitumor effects and mechanisms of dendritic cells stimulated by sCD40L on ovarian cancer cells in vitro

Author(s): Zhang ZM | Yang XM | Zhang C | Zhang MJ | Li X | Zhang FH | Kang S | Wang SJ | Shan BE
Volume: 2013
Issue: default
Year: 2013
Expression of novel tumor markers of pancreatic adenocarcinomas in intrahepatic cholangiocarcinomas

Author(s): Zong M | Jia L | Li L
Volume: 2013
Issue: default
Year: 2013
Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells

Author(s): Chen YH | Wang JY | Pan BS | Mu YF | Lai MS | So EC | Wong TS | Huang BM
Volume: 2013
Issue: default
Year: 2013
Dose-effect relationship of CpG oligodeoxyribonucleotide 1826 in murine Lewis lung cancer treated with irradiation

Author(s): Zhuang XB | Qiao TK | Yuan SJ | Chen W | Zha L | Yan L
Volume: 2013
Issue: default
Year: 2013
Circadian rhythm characteristics of oral squamous cell carcinoma growth in an orthotopic xenograft model

Author(s): Zhao NB | Tang H | Yang K | Chen D
Volume: 2013
Issue: default
Year: 2013
Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells

Author(s): Alarifi S | Ali D | Alkahtani S | Siddiqui MA | Ali BA
Volume: 2013
Issue: default
Year: 2013
Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli

Author(s): Han JB | Sang F | Chang JJ | Hua YQ | Shi WD | Tang LH | Liu LM
Volume: 2013
Issue: default
Year: 2013
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

Author(s): Nelson V | Ziehr J | Agulnik M | Johnson M
Volume: 2013
Issue: default
Year: 2013
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

Author(s): Diaz-Miqueli A | Saurez Martinez G
Volume: 2013
Issue: default
Year: 2013
Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial

Author(s): Liang J | E M | Wu G | Zhao L | Li X | Xiu X | Li N | Chen B | Hui Z | Lv J | Fang H | Tang Y | Bi N | Wang W | Zhai Y | Li T | Chen D | Zou SM | Lu N | Perez-Rodríguez R | Zheng J | Wang L
Volume: 2013
Issue: default
Year: 2013
Long-term results of a randomized controlled trial evaluating preoperative chemotherapy in resectable non-small cell lung cancer

Author(s): Chen ZW | Luo QQ | Jian H | Zhou Z | Cheng BJ | Lu S | Liao ML
Volume: 2013
Issue: default
Year: 2013
Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia

Author(s): Cross M | Bach E | Tran T | Krahl R | Jaekel N | Niederwieser D | Junghanss C | Maschmeyer G | Al-Ali HK
Volume: 2013
Issue: default
Year: 2013
New and emerging treatment options for biliary tract cancer

Author(s): Noel MS | Hezel AF
Volume: 2013
Issue: default
Year: 2013
Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients

Author(s): He L | Peng K | Liu Y | Xiong J | Zhu FF
Volume: 2013
Issue: default
Year: 2013
Systematic review of dasatinib in chronic myeloid leukemia

Author(s): Breccia M | Salaroli A | Molica M | Alimena G
Volume: 2013
Issue: default
Year: 2013
PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma

Author(s): Zhang L | Shi L | Zhao X | Wang Y | Yue W
Volume: 2013
Issue: default
Year: 2013
Targeting cancer stem cells: emerging role of Nanog transcription factor

Author(s): Wang ML | Chiou SH | Wu CW
Volume: 2013
Issue: default
Year: 2013
Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors

Author(s): Zhang Z | Hao C | Wang L | Liu P | Zhao L | Zhu C | Tian X
Volume: 2013
Issue: default
Year: 2013
Resveratrol decreases B-cell lymphoma-2 expression and viability in GH3 pituitary adenoma cells of the rat

Author(s): Voellger B | Kirches E | Wilisch-Neumann A | Weise A | Tapia-Perez JH | Rupa R | Mawrin C | Firsching R
Volume: 2013
Issue: default
Year: 2013
The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells

Author(s): Chai F | Zhou J | Chen C | Xie S | Chen X | Su P | Shi J
Volume: 2013
Issue: default
Year: 2013
Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment

Author(s): Rachmut IH | Samuels N | Melnick SJ | Ramachandran C | Sharabi Y | Pavlovsky A | Maimon Y | Shoham J
Volume: 2013
Issue: default
Year: 2013
Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today

Author(s): Kallianos A | Tsimpoukis S | Zarogoulidis P | Darwiche K | Charpidou A | Tsioulis I | Trakada G | Porpodis K | Spyratos D | Panoutspoulos A | Veletza L | Kostopoulos K | Kostopoulos C | Karapantzos I | Tsakiridis K | Hohenforst-Schmidt W | Zarogoulidis K | Rapti A | Syrigos K
Volume: 2013
Issue: default
Year: 2013
Pulmonary adenocarcinoma with osseous metaplasia: a rare occurrence possibly associated with early stage?

Author(s): Zhang Q | Yin L | Li B | Meng R | Dao R | Hu S | Qiu X
Volume: 2013
Issue: default
Year: 2013
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer

Author(s): Boutsikou E | Kontakiotis T | Zarogoulidis P | Darwiche K | Eleptheriadou E | Porpodis K | Galaktidou G | Sakkas L | Hohenforst-Schmidt W | Tsakiridis K | Karaiskos T | Zarogoulidis K
Volume: 2013
Issue: default
Year: 2013
Potential use of custirsen to treat prostate cancer

Author(s): Higano CS
Volume: 2013
Issue: default
Year: 2013
Potential of ponatinib to treat chronic myeloid leukemia and acute lymphoblastic leukemia

Author(s): Price KE | Saleem N | Lee G | Steinberg M
Volume: 2013
Issue: default
Year: 2013
Apoptosis and G2/M arrest induced by Allium ursinum (ramson) watery extract in an AGS gastric cancer cell line

Author(s): Xu XY | Song GQ | Yu YQ | Ma HY | Ma L | Jin YN
Volume: 2013
Issue: default
Year: 2013
Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer

Author(s): Ono M | Ito T | Kanai T | Murayama K | Koyama H | Maeno K | Mochizuki Y | Iesato A | Hanamura T | Okada T | Watanabe T | Ito K
Volume: 2013
Issue: default
Year: 2013
Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model

Author(s): Kim DY | Song KJ | Kim SU | Yoo EJ | Park JY | Ahn SH | Han KH
Volume: 2013
Issue: default
Year: 2013
Resting-state magnetoencephalography study of “small world” characteristics and cognitive dysfunction in patients with glioma

Author(s): Hu X | Lei T | Xu HZ | Zou YJ | Liu HY
Volume: 2013
Issue: default
Year: 2013
Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer

Author(s): Xu R | Ma N | Wang F | Ma L | Chen R | Chen R | Kebinu M | Ma LL | Han ZC | Ayixiamu | Mayier M | Su PC | Naman YM | Jieensi H | Yang HX | Adili A | Aili S | Liu J
Volume: 2013
Issue: default
Year: 2013
A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer

Author(s): Ding C | Li C | Wang H | Li B | Guo Z
Volume: 2013
Issue: default
Year: 2013
Prognostic factors associated with solitary plasmacytoma

Author(s): Guo SQ | Zhang L | Wang YF | Sun BC | Zhang LY | Zhang J | Wang GW | Zhang YZ
Volume: 2013
Issue: default
Year: 2013
Pseudomembranous colitis within radiotherapy field following concurrent chemoradiation therapy: a case report

Author(s): Shen BJ | Lin SC | Shueng PW | Chou YH | Tseng LM | Hsieh CH
Volume: 2013
Issue: default
Year: 2013
AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines

Author(s): Leal P | Garcia P | Sandoval A | Buchegger K | Weber H | Tapia O | Roa JC
Volume: 2013
Issue: default
Year: 2013
Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma

Author(s): Wang D | Yang JX | Cao DY | Wan XR | Feng FZ | Huang HF | Shen K | Xiang Y
Volume: 2013
Issue: default
Year: 2013
Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial

Author(s): Ueda A | Hosokawa A | Ogawa K | Yoshita H | Ando T | Kajiura S | Fujinami H | Kawai K | Nishikawa J | Tajiri K | Minemura M | Sugiyama T
Volume: 2013
Issue: default
Year: 2013
RPA Switzerland

RPA Switzerland

Robotic process automation

    

Tango Rapperswil
Tango Rapperswil